Soliphen 15mg Tablets for Dogs - Single Tablet

Soliphen 15 mg tablets for dogs
Active substance:
Phenobarbital................................. 15 mg

Prevention of seizures due to generalised epilepsy in dogs.

Contraindications
Do not administer to animals with seriously impaired hepatic function.
Do not use in animals with serious renal or cardiovascular disorders.
Do not use in dogs weighing less than 6 kg body weight.
Do not use in cases of (known) hypersensitivity to the active substance or to any other
barbiturates or to any of the excipients.

 Special warnings for each target species
The decision to start antiepileptic drug therapy with phenobarbital should be evaluated for
each individual case and depends on number, frequency, duration and severity of seizures
in dogs.
General recommendations for initiating therapy include a single seizure occurring more
than once every 4-6 weeks, cluster seizure activity (i.e. more than one seizure within 24 h)
or status epilepticus regardless of frequency.
Therapeutic phenobarbital serum concentrations should be monitored to enable the lowest
effective dose to be used. Typically, concentrations of 15-40 g/ml are effective in
controlling epilepsy.
Some of the dogs are free of epileptic seizures during the treatment, but some of the dogs
show only a seizure reduction, and some of the dogs are considered to be nonresponders.